Tue, September 10, 2024
Mon, September 9, 2024
Fri, September 6, 2024
Thu, September 5, 2024

Raghuram Selvaraju Reiterated (BTAI) at Strong Buy and Held Target at $7 on, Sep 6th, 2024


//stocks-investing.news-articles.net/content/202 .. ng-buy-and-held-target-at-7-on-sep-6th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $7 on, Sep 6th, 2024.

Raghuram has made no other calls on BTAI in the last 4 months.



There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 1 agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $1 on, Friday, August 9th, 2024


This is the rating of the analyst that currently disagrees with Raghuram


  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy and Held Target at $7 on, Friday, August 30th, 2024

Publication Contributing Sources